$35.00
-0.73 (-2.04%)
Open$35.35
Previous Close$35.73
Day High$36.98
Day Low$34.01
52W High$41.42
52W Low$4.97
Volume—
Avg Volume2.33M
Market Cap91.22M
P/E Ratio—
EPS$-4.61
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
-55.0% upside
Current
$35.00
$35.00
Target
$15.75
$15.75
$10.91
$15.75 avg
$18.65
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.67M | 17.68M | 17.52M |
| Net Income | -21,958,070 | -69,679,191 | -1,532,650 |
| Profit Margin | -96.9% | -416.1% | -8.8% |
| EBITDA | -21,639,331 | -74,344,734 | -1,913,244 |
| Free Cash Flow | — | — | -1,533,941 |
| Rev Growth | +180.1% | -14.7% | +0.6% |
| Debt/Equity | — | 0.25 | 1.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |